APCext : Effect of Temporary Porto-caval Shunt During Liver Transplantation on Function of Liver Graft From Extended Criteria Donor (APCext)

  • End date
    Jul 14, 2024
  • participants needed
  • sponsor
    Rennes University Hospital
Updated on 14 May 2022
organ transplantation
cardiac arrest
liver disease
reperfusion injury
orthotopic liver transplant


The success of orthotopic liver transplantation (OLT) in treatment of liver malignancy and endstage liver disease has led to an increase in the gap between patients on waiting-lists and available liver grafts. In order to compensate for this scarcity, use of liver grafts harvested from extended criteria donors (ECD) has become more and more frequent.

However, these ECD grafts are known to be associated with a higher rate of primary non function (PNF) or early allograft dysfunction (EAD) because of a greater vulnerability to ischemia-reperfusion injury (IRI).

During OLT, the clamping of the portal vein induces blood congestion in the splanchnic territory leading to increased gut permeability, bacterial translocation and release of endotoxin and pro-inflammatory cytokines at revascularisation, which exacerbate IRI.

Realisation of a temporary porto-caval shunt (TPCS) (i.e. end to side anastomosis between the portal vein and infrahepatic vena cava) during the anhepatic phase, avoids splanchnic congestion and could therefore decrease IRI and improve liver graft function. However, TPCS remains poorly used as no randomised trial succeeds to show its benefit on liver function due to lack of power.

Condition Liver Transplantation
Treatment temporary porto-caval shunt
Clinical Study IdentifierNCT02784119
SponsorRennes University Hospital
Last Modified on14 May 2022


Yes No Not Sure

Inclusion Criteria

Age ≥ 18 years old
Candidate of liver transplantation
With cirrhosis from any etiology
Model For End-Stage Liver Disease (MELD) score < 25
Transplanted with a liver graft harvested from an extended criteria donor defined as presence of at least one of the following criteria
Donor age > 65 years old
Intensive care unit stay > 7 days
BMI > 30
Natremia > 155 mmol/L
Aspartate aminotransferase (ASAT) > 150 IU/mL
Alanine aminotransferase (ALAT) > 170 IU/mL
Occurrence of a cardiac arrest before graft harvesting
Proven biopsy macrosteathosis > 30%
Non-opposition from the patient
Non Inclusion Criteria
Fulminant hepatitis
Combined organ transplantation (kidney, pancreas, heart, lung)
Non heart beating donor
Complete portal vein thrombosis on preoperative imaging finding

Exclusion Criteria

Complete portal vein thrombosis found during procedure
Split liver graft
Realisation of a bilio-enteric anastomosis
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note